The health insurer saw operating revenues climb 11 percent to $11.5 billion, compared to $10.4 billion reported in the same period a year prior. Cigna attributed the gains in part to growth in its global healthcare and supplemental benefits segments, as well as higher premiums.
At the same time, Cigna saw its expenses grow 12 percent to $10.4 billion, up from $9.3 billion in the same quarter a year prior.
Cigna ended the quarter with net income of $806 million, down 1 percent from $813 million reported in the same period of 2017.
However, the health insurer faces opposition for its proposed $54 billion takeover of Express Scripts. On Aug. 1, The Wall Street Journal revealed Carl Icahn, an activist investor, intends to vote against the deal. Cigna CEO David Cordani told analysts during an Aug. 2 earnings call that the deal is in the interest of shareholders.
More articles on payers:
50K BCBS members to lose in-network access to Duke Health, WakeMed
Trump administration releases final rule for short-term health plans: 5 things to know
CMS approves Maine’s health insurance waiver: 4 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
